1. European Monitoring Center for Drugs and Drug Addiction [cited 2017 Aug 11]. Available from: http://www.emcdda.europa.eu/system/files/publications/4502/TD0116924ENN.pdf_en
2. Vukovic O, Maric NP, Britvic D, Cvetic T, Damjanovic A, Prostran M, Miroslava JG. Efficacy, tolerability and safety of tıaneptine in special populations of depressive patients, Psychiatria Donubina. 2009;21:194-198
3. Saatciogli O, Erim R, Cakmak D. Tiyaneptin kotuye kulanimi: bir olgu sunumu, Turkish Journal of Psychiatry. 2006;17:72-75
4. Gassaway MM, Rives ML, Kruegel AC, Javitch JA, Sames D. The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist, Translational Psychiatry. 2014; 4: e411
5. Malka R, Loo H, Ganry H, Souche A, MareyC, Kamoun A. Long-term administration tianeptine in depressed patients after alcohol withdrawal. Br J Psychiatry 1992;15: 66-71